No More Silence: US FDA Clears First-Ever Gene Therapy For Children Born Deaf Due To Genetic Mutation
American drugmaker Regeneron's Otarmeni can restore natural hearing in children born deaf due to a genetic mutation
American drugmaker Regeneron's Otarmeni can restore natural hearing in children born deaf due to a genetic mutation
What's Your Reaction?
